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CHAPTER 1: BACKGROUND AND SIGNIFICANCE 
Degenerative photoreceptor diseases and vision loss 
The retina is a specialized neuronal tissue of the vertebrate eye consisting of 
multiple different cell types with distinct morphology and synaptic connections 
orchestrated in layers (Figure 1). Photoreceptors (PRs) are the main retinal cells 
involved in initiating visual signal processing, especially for image forming vision. There 
are two types of PRs found in a mammalian retina, i.e. rods and cones. PRs carry a 
special type of protein called opsin, i.e. rod-opsin and cone-opsin. Rod and cone opsins 
combine with chromophore 11-cis retinal form photosensitive rhodopsins in rod and 
photopsins in cones (together also called photopigments) respectively, which enables 
them to sense the light (photon). Rod and cone photopigments belong to the family of 
G-protein coupled receptors (GPCRS) (Spudich et al., 2000; Placzewski, 2006). The rod 
and cone PRs facilitate scotopic (in dark or dim light) and photopic (day light) vision, 
respectively. Additionally, there are three types of cone photopigments with their peak 
spectral sensitivity at blue (λmax ~425 nm), green (λmax ~530 nm), and red (λmax ~560 
nm), enabling color vision (Nathans et al., 1986; Oprian et al., 1991; Ernst et al., 2013). 
The visual signal pathways are complex and tightly regulated by different retinal 
cell types. In responding to light PRs reduce the release of neurotransmitter glutamate 
and relay the information to horizontal and bipolar cells. Horizontal cells provide an 
inhibitory feedback signal to PRs and thereby emphasize differences in signaling 
strength among neighboring PRs. Bipolar cells segregate PR’s signals to multiple 
parallel pathways. Bipolar cells sort the signal and passes to amacrine and ganglion 
cells. Both bipolar cells and ganglion cells broadly classified into ON and OFF types 
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according to their light response polarity. In light, both of the ON type of bipolar and 
ganglion cells depolarize whereas, the OFF types hyperpolarize to generate ON and 
OFF responses, respectively.  Reversibly, in dark both the OFF type of bipolar and 
ganglion cells depolarize while the ON types hyperpolarize. Based on such prime 
responses, visual processing pathways are divided into ON-pathway and OFF-pathway 
modes (Wassle, 2004; Zhang et al., 2009). 
 
Figure 1: Schematic of the major retinal cell types of the human retina. 
In general, retinal ganglion cells integrate signals from the bipolar cells and 
convey them via the optic nerve to the higher visual processing centers in the brain. 
These integrated signals include information about many parameters, such as i) Spatial 
information, e.g. object location, ii) Temporal information, i.e. variations with time or 
movement of an object, iii) Light intensity, and iv) Color. The summation of all these 
creates an image and scene. Thus, PRs are essential for initiating visual signal 
perception.  
Many blinding diseases occur because of loss of function and/or degeneration of 
PRs (Figure 2). Examples include retinitis pigmentosa (RP) and age-related macular 
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degeneration (AMD). The worldwide prevalence of RP is estimated as 1 in ~4000 
people (https://nei.nih.gov/health/pigmentosa/pigmentosa_facts, last updated December 
2015), i.e. ~1.84 millions of people worldwide (calculated based on world population in 
2015). The RP is heterogeneous disease caused by either genetic defects in the PRs 
leading to dysfunction or genetically damaged retinal pigment epithelium (RPE) cells 
failing to recycle the retinal chromophore (Hartong et al., 2006). To date, over 110 
genes (RetNet, http://www.sph.uth.tmc.edu/RetNet/; last updated January 4, 2019), and 
over 3000 mutations have been identified to be associated with the RP (Daiger et al., 
2013). AMD is more prevalent in older people. AMD patient population is projected to 
grow up to 196 million by 2020 (Wong et al., 2014). The visual impairment in AMD 
occurs specifically in the macular region, a center point of the retina, which involves 
high acuity visual functions (de Jong, 2006). Both of these diseases are still lacking 
efficient treatments. 
 
Figure 2: Schematic of the photoreceptor degeneration mediated vision loss. Loss of 
photoreceptors leaves bipolar cells and ganglion cells unresponsive to the light, especially for the image 
forming vision, and blocks the flow of visual information that ultimately causes vision loss. 
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Previous studies of postmortem human retinal tissues have revealed that second 
and third order retinal neurons remain partially preserved after the death of PRs (Stone 
et al., 1992; Santos et al., 1997; Milam et al., 1998). Similar observations in animal 
models of retinal degeneration were also reported (Chang et al., 2002; Olshevkaya et 
al., 2004; Lin et al., 2013). At the same time, following PRs degeneration the retinal 
remodeling was also observed (Fariss et al., 2000; Marc et al., 2003). The preserved 
retinal neurons have set the bases for the development of treatment strategies, 
discussed below, whereas the retina remodeling may limit the expected level of vision 
restoration. 
Strategies for treating RP and AMD 
Many attempts to stop, slow down, or reverse the PR degeneration have been 
made (Cai et al., 2000; Cideciyan, 2010; Berson et al., 2012; Wen et al., 2012; Cuenca 
et al., 2014). Unfortunately, no success has been achieved for these attempts so far, 
and PR degeneration is still inevitable and irreversible. However, there are some other 
promising approaches include gene replacement therapy, retinal prosthesis, 
optogenetics, stem cell implantation, and endogenous regeneration which are currently 
under investigation to treat blindness caused by PR degeneration (Scholl et al., 2016; 
The Lasker Foundation report, 2014). 
Gene replacement therapy is about genetically inserting a wild type copy of the 
gene mutated in a specific cell type. The gene therapy for RPE65 gene mutation 
associated Leber congenital amaurosis (LCA), commercially known as Luxturna 
(voretigene neparvovec-rzyl), is a first gene therapy drug approved by FDA for clinical 
use (FDA News release, December 19, 2017). However, this is only applicable to the 
patient carrying the mutation in RPE65 gene. More recently, proof-of-concept study on 
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mutation-independent rhodopsin gene replacement therapy has been reported 
(Cideciyan et al., 2018). It has proposed to knockdown mutant rhodopsin gene 
expression and introducing the wild type one, by single adeno-associated viral (AAV) 
vector carrying sequences that encode both the knockdown shRNA (short RNA) 
element and the replacement rhodopsin protein. Indeed, this seems to have great 
potential, but it is essential to have intact PRs.  
The retinal prosthesis approach employs an implant of an electronic chip with 
multiple micro-electrodes that can electrically stimulate second or third order retinal 
neurons, i.e. bipolar cells or ganglion cells. Based on placement of these implants, they 
can be typically classified as epiretinal, subretinal and suprachoroidal implants. Both, 
epiretinal and suprachoroidal implants have light sensors connected extra-occularly, 
while subretinal implants have light sensors coupled with stimulating electrodes. 
Primarily, subretinal and suprachoroidal implants stimulate bipolar cells while epiretinal 
implants stimulate ganglion cells. Examples include Argus II and Alpha-IMS systems 
that are now commercialized. However, the best-restored visual acuity is reported to be 
20/546 (Stingl et al., 2013), which is still worse than 20/200 which is defined as legally 
blind in US. Therefore, the development of effective retinal prostheses is facing huge 
technical challenges (The Lasker Foundation report, 2014).  
Implanting stem cells that are programmed to differentiate into PR cells is 
another strategy under research (Lund et al., 2001; Lamba et al., 2009; West et al., 
2009). Stimulating endogenous retinal regeneration, specifically PRs regeneration, has 
also been considered. Recent report has shown successful regeneration of PRs by 
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stimulating endogenous retinal Muller glia cells in a mouse model, yet it only proved the 
feasibility of the approach and needs further development (Yao et al., 2018).   
Optogenetic strategy is based on imparting photo-sensitivity in the RP 
degenerative retina via expressing genetically encoded light sensors in inner retinal 
neurons. Details of this approach are discussed further in next section. Another 
approach involves the use of chemical or optopharmacological photoswitches which are 
conjugated with native ion-channels or ectopic expressed receptors to render light 
sensitivity to the degenerative retina. The photoswitches upon light activation alters the 
state of ion-channels or ligand-gated receptors and causes them to generate electrical 
signals. Two examples are DENAQ (diethylamine-azobenzene-quaternary ammonium; 
Tochitsky et al. 2014) and MPC088 (Yue et al., 2012). Both, DENAQ and MPC088 are 
chemically azobenzene derivatives, and undergo cis/trans isomerization upon light 
stimulation. The DENAQ was designed to regulate hyperpolarization-activated cyclic 
nucleotide-gated (HCN), and has spectral sensitivity between 450-500 nm. The 
MPC088 was designed to regulate ligand-gated receptors such as glutamate and GABA 
receptors. A potential drawback of the chemical photoswitches is their short life span 
requiring its continuous supply (Pan et al., 2015).  
Rhodopsin based optogenetic approaches  
In 2003, a novel optogenetic approach was launched (Bi et al., 2006; Pan et al., 
2015). This strategy is based on converting surviving inner retinal neurons into 
photosensitive cells, thus imparting light sensitivity to a retina affected by PR 
degeneration. Technically, this could be achieved by introducing light sensing proteins 
in the plasma membrane of bipolar cells or ganglion cells (Figure 3A). Critical to the 
feasibility of this approach is to have suitable genetically encoded light sensors. 
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Figure 3: Optogenetic strategy and optogenetic light sensor. A) Schematic of optogenetic vision 
restoration via targeted expression of ChR; the yellow colored cells with red outlines indicate expression 
of channelrhodopsin (ChR). B) Schematic of ChR structure and light activation. 
The discovery of channelrhodopsin-1 (ChR1) and channelrhodopsin-2 (ChR2) 
(Nagel et al., 2002 and 2003) led to the development of technology known as 
“Optogenetics” (Deisseroth, 2006), which is to excite a neuronal cell with light and study 
its effect on connected networks, specifically in brain tissue which was previously 
B 
A 
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inaccessible (Yizhar et al., 2011). In addition, it prompted the beginning of exploring the 
optogenetic approach to restore vision (Bi et al., 2006). ChR1 and ChR2 are blue light 
sensitive, non-selective cation channels from the green alga species Chlamydomonas 
reinhardtii. They are microbial type (type1) rhodopsin (Spudich et al., 2000). In general, 
ChR1 and ChR2 are cell membrane proteins composed of extracellular amino terminal 
(N’) with seven trans-membrane (TM) helixes (TMH), intracellular carboxyl terminal (C’) 
and a chromophore, i.e. all-trans retinal (ATR), covalently attached. The seven TMHs 
are linked via either extracellular loop (ECL) or intracellular loop (ICL) domains (Figure 
3B). Throughout this document, TMHs are described with respective number, for 
instance TMH one as TM1 or TM1. 
The attached chromophore ATR enables ChRs to sense the light of particular 
wavelengths, which is mostly in the range of 400-600 nm. Upon light stimulation, ATR 
isomerizes to 13-cis retinal conformation. Subsequently, many conformational changes 
in TMHs take place and initiate channel opening that ultimately leads to cation flux into 
the cell (Figure 3B). Such cation influx increases the intracellular cation concentration 
and, as a result, the cell’s membrane potential depolarizes. ChR functions as sensory 
PRs and guide the algae for phototaxis based on light intensity and availability. Wild 
type ChRs (ChRs-Wt) proteins are more than 600 amino acids long, encompassing a 
very long C-terminus. In the green algae, such long C-terminus assists ChRs in 
trafficking to eyespot (Awasthi et al., 2016). However, it is not required for their ion-
channel activity, instead only the first 300-350 amino acid residues are sufficient (Nagel 
et al. 2005).  
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Proof of concept studies 
The first proof of concept for optogenetic approach to restore vision 
demonstrated that ectopic expression of ChR2 in the retinal ganglion cells could restore 
visual response in rd1 mouse, a mouse model of PRs degeneration (Bi et al., 2006). In 
this study, adeno-associated virus serotype 2 (AAV2) carrying ChR2-GFP transgene 
was injected intravitreally into the eye and the ChR2 was shown to express stably in the 
retinal ganglion cells. The transfected retinal ganglion cells (expressing ChR2) were 
shown to fire action potential in response to the blue light (460nm) specifically, 
indicating ChR2 mediated light responses. Using similar strategy, Tomita et al., (2007, 
2010) also showed successful restoration of optomotor response in Royal College of 
Surgeons (RCS) rat model of RP. Both of these groups demonstrated use of ChR2 to 
regenerate ON response in different animal models.  Furthermore, long-term stable 
expression of ChR2 in vivo with restored photosensitivity lasting for nearly an entire life 
span (64 weeks) of murine models had also been validated (Ivanova et al., 2009 and 
2010). 
On the other hand, Busskamp et al., (2010) used halorhodopsin (eNpHR) which 
functions as a hyperpolarizing optogenetic tool, and expected to generate OFF 
response from transfected remaining cones. Progressively, many successful attempts to 
generate both ON and OFF responses in the diseased retina (mouse or rabbit models) 
by dual transduction of ChR and halorhodopsin (NpHR/eNpHR) were also made (Zhang 
et al., 2009; Greenberg et al., 2011; Wu et al., 2013). Additionally, the retinal cell 
specific expression of ChRs in ON bipolar cells were made possible using either an 
optimized promoter, e.g. mGluR6, or its combination with a capsid mutant variant of 
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AAV, e.g. AAV2/8 (Lagali et al., 2008; Doroudchi et al., 2011; Cronin et al., 2014; Lu et 
al., 2016).  
Thus, ChR based optogenetic strategies are promising for vision restoration in 
PR degenerative diseases. Furthermore, the vertebrate opsin based optogenetic 
approach, i.e. using melanopsin or human rod-opsin instead of ChRs, had also been 
tested (Lin et al., 2008; Cehajic-Kapetanovic et al., 2015). There are advantages and 
limitations of ChRs as an optogenetic tool as described below. 
Channelrhodopsins (ChRs) as an optogenetic tool 
There are several advantages of using ChRs as an optogenetic tool. First, unlike 
an animal rhodopsin, ChRs provide both light sensitivity and ion-conducting property 
without any secondary signal cascade event. Second, their chromophore ATR does not 
detach from opsin during light activation, and is capable of re-isomerizing, i.e. from 13-
cis to all-trans conformation, by itself in dark. Hence, ChRs can work in the inner retinal 
neurons which are away from the RPE and cause no photo-bleaching. Third, the ATR 
isoform is abundantly present in all cell types in mammals, and thus, no exogenous 
supply of chromophore needs (Bi et al., 2006). Forth, ChRs have fast on-off kinetics 
compared to melanopsin (Pan et al., 2015). Finally, there are ChR variants with different 
peak spectral sensitivity, which may provide the potential to restore color vision in the 
future.  
On the other hand, although the ChR based optogenetics could restored light 
sensitivity in the diseased retina, a major limitation of using wt-ChRs as an optogenetic 
tool is their low-light sensitivity. In the optogenetically treated retina, the ganglion cells 
fire action potentials evoked by ChR2-meditaed membrane depolarization in response 
to light. Therefore, the light sensitivity of the transfected retinal ganglion cells is 
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dependent on the light sensitivity of an individual ChR, which is referred to as 
operational light sensitivity of the ChR (Mattis et al., 2012; Pan et al., 2014). The 
minimal required light intensity to activate ChR2-Wt expressing retinal ganglion cells is 
close to 1015 photons/cm2s (Pan et al., 2014). In contrast, the light activation thresholds 
for rods and cones are ~1010 photons/cm2s and ~106 photons/cm2s, respectively (Lagali 
et al., 2008). Thus, the light sensitivity of ChR2-Wt expressing retinal ganglion cells is at 
least 4-5 log units lower than that of cones. Recently, via molecular engineering, the 
operational light sensitivity of ChR2 was improved up to ~2 log unit, e.g. ChR2-
L132C/T159S mutant variant (Figure 4; Pan et al., 2014). However, the improved light 
sensitivity of ChR2 is still ~3 log unit lower than cone threshold and needs further 
enhancement. 
Additionally, ChR variants with improved light sensitivity are blue light sensitive. 
An extra-ocular imaging device has been proposed for use in combination with available 
optogenetic tools in order to overcome the low light sensitivity of ChRs (Barrett et al., 
2014). Such device enhances the visual signal (in terms of light intensity) to better fit 
into ChR’s sensitivity range. However, the blue light at high light intensities can 
potentially damage retinal tissue by phototoxicity since photons of shorter wavelength 
light have higher energy than that of longer wavelength light (red light). Therefore, 
shifting the peak spectrum sensitivity (λmax) towards the red is also desired (Pan et al., 
2015).  
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Figure 4: Comparison of light sensitivity range of different opsins. Note that threshold is higher for 
different ChRs, which were estimated from their expressing retinal ganglion cells. (Adapted from Pan et 
al., 2015). 
In conclusion, ChRs are the superior choice as optogenetic tools because of their 
fast kinetics, simple signal transduction pathway, and potential of improving their light 
sensitivity by molecular engineering. 
Optimizing light sensitivity of ChRs 
As mentioned earlier, the light sensitivity of the ChR treated retina largely 
depends on the operational light sensitivity of the ChR used. Thus, optimizing ChR’s 
light sensitivity is to create a ChR variant that can generate large photocurrent, 
especially at lower light intensity (Pan et al., 2014). Understanding the ChR mechanism 
of action is a key to improving its light response properties. 
In the dark, when channel is closed complex bonding between definite amino 
acids block its cation permeation pathway. Essentially, upon light stimulation 
reorientation of the chromophore ATR and changes in hydrogen bond networking opens 
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the channel. The channel opening and closing is termed as “On-gating” and “Off-gating” 
respectively (Hegemann et al., 2005; Nikolic et al., 2009; Lorenz-Fonfria et al., 2014). 
For the ChR2, several amino acid residues have been identified to play critical role in 
regulating its gating. Some of the polar amino acid residues form cation accumulation 
site and two gates, i.e. ‘central gate’ and ‘inner gate’ that are key structural elements for 
ion conduction pathway. In ChR2, the central gate is formed by S63, E90 and N258, 
and the inner gate is formed by E82, E83, H134 and H265 (Kato et al., 2012; Schneider 
et al., 2015). Complex hydrogen bonding network at both of these gates keeps the 
channels close internally and prevent the cation and water flow from the cell. Mutating 
central gate residues have resulted in reduced photocurrent, e.g. ChR2-E90Q/A, N258D 
(Kato et al., 2012). 
Apart from all these, residues C128 and D156 of the ChR2 are fundamentally 
relevant to its gating and were found linked via hydrogen bond, better referred as either 
“DC-pair” or “DC-gate” (Kato et al., 2012; Schneider et al., 2015). Both, weakening and 
recovery of the DC-gate hydrogen bond during channel opening and closing state, 
respectively, have been reported (Nack et al., 2010). Moreover, individual or combined 
mutations at these sites evidently showed retarded “Off-gating” seizing channel open 
state (Berndt et al., 2009). Because of their stable extended channel open state, these 
DC-gate mutants, especially the mutant variants ChR2-C128T/S/A and ChR2-
C128S/D156A, could responded to the light at 300-fold lower intensity level than ChR2-
Wt (Berndt et al., 2009; Yizhar et al., 2011). Thus, these DC-gate mutant variants of 
ChR2 showed improved light sensitivity, however, they are too slow to be useful for 
vision restoration purposes. Nevertheless, an important outcome of these mutant 
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studies is that slowing off-kinetics of ChRs can improve its light sensitivity. It is 
hypothesized that extended channel open state of DC-gate mutant variants allows more 
cation influx that in turn makes them more operationally light sensitive. Discussed below 
are some of the engineered variants with marked altered properties 
Molecular engineering based ChR variants with altered light sensitivity 
Hereafter, the term “ChR variants” refers to the ChRs from different algae 
species, ChRs with any modification including a single base pair mutation to multiple 
mutations, and chimeras. Since the discovery of ChR1 and ChR2, many attempted to 
explore the molecular determinants of their respective properties like photocurrent 
kinetics and spectral sensitivity. Additionally, several consecutive efforts made to 
improve ChR2 functional properties. The primary approach used was site directed 
mutagenesis to create mutant variants and determine its role in channel function.  
Although both ChR1 and ChR2 are from the same algal specie Chlamydomonas 
reinhardtii, and shares ~65% sequence similarity, they have major differences in their 
peak spectral sensitivity (λmax), ion selectivity, as well as  activation, desensitization, and 
deactivation kinetics (Nagel, G. et al., 2002, 2003). Specifically, these differences are: (i) 
ChR1 has its λmax around 500 nm which is red shifted compared to 460 nm λmax of ChR2, 
(ii) ChR1 is more of proton (H+) selective, while ChR2 prefer other cations, e.g. Na+, K+, 
Ca++, and hence can function at physiological pH, (iii) ChR1 exhibits less 
desensitization than ChR2 in response to continuous light stimulation (Nagel et al., 2002, 
2003; Lin et al., 2009). Such differences also exist among other ChRs (Mattis et al., 
2012; Weiteck et al., 2016). In 2009, Lin Y.J. et al. reported a chimera variant “ChIEF” in 
which TM5 (E) to TM6 (F) of ChR1 were replaced with that of ChR2 and a point 
mutation I170V (ChEF-number) was introduced. This ChIEF was shown to exhibit 
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reduced desensitization like ChR1, and large current amplitude like ChR2. This was the 
first successful attempt reported to improve ChR properties, and importantly, it involved 
molecular engineering techniques like chimera design, and site-directed mutagenesis. 
Similar efforts were continued following this report. In 2010, Gunaydin et al. reported 
another interesting variant “ChETA” (ChR2-E123T accelerated) with fastest channel 
kinetics. Berndt, A. et al. (2011) targeted several mutations in ATR binding pocket 
region of ChR2 and found the variant “ChR2-T159C”, which exhibited large 
photocurrent than wild type ChR2. Kleinlogel et al. (2011) reported an ultra-light 
sensitive ChR2 variant “CatCh” (ChR2-L132C) that was named after its calcium ion 
(Ca++) permeability. They proposed a new principle that shifting the ion-channel’s 
permeability from monovalent to divalent cations will increase sensitivity without altering 
kinetics. Additionally, double mutant ChR2-L132C/T159C showed further improvement 
in photocurrent generated (Prigge et al., 2012). 
Several other improved mutant variants of ChR2 namely ChR2-L132A/T159C, 
and ChR2-L132C/T159S were recently reported (Pan et al., 2014). In particular, the 
operational light sensitivity of ChR2-L132C/T159S variant was shown to be improved up 
to 2 log units compared to the ChR2-Wt  (Figure 4), which was a significant 
improvement considering its applicability in restoring vision via optogenetic approach. 
The study concluded that the prolonged off rate, indicating extended channel open state, 
allowed greater cation influx and hence increased operational light sensitivity of mutant 
ChR2 variants (Pan et al., 2014). Nevertheless, channel’s kinetics put a limit to an 
extent ChRs light sensitivity could be improved. Specifically, Pan et al. (2014) projected 
limiting slower off rate to 1 second based on their results of temporal coding ability of 
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the retinal ganglion cells expressing ChR2 mutants (with an off rate up to ~1 s). Since 
this limit has already been reached for ChR2, targeting new ChR variants with naturally 
superior photocurrent properties is one of the possible ways to develop better 
optogenetic tool to restore vision. Discussed below are some of the potential candidates. 
Newly discovered ChRs with potential to be better light sensitive optogenetic 
tools 
Recently, around sixty different algal ChRs were discovered (Klapoetke et al., 
2014). Two of these many new ChRs, CoChR and Chrimson (CnChR1), were 
considered for this study. The CoChR is from the species Chloromonas oogama (Co), 
and was shown to generate large photocurrent than ChR2 at its peak spectral sensitivity 
(λmax) around 470 nm. The CnChR1, from the species Chlamydomonas noctigama (Cn), 
was named as Chrimson because of its sensitivity to far-red spectrum of 660 nm and 
λmax at 590 nm. The reported channel properties are summarized in the Table1. From 
the Table-1, it is clear that the CoChR was one of the highest photocurrents producing 
ChR reported. Especially at the 470 nm CoChR was shown to generate roughly seven-
fold higher current than that of the ChR2. The light response kinetics, particularly 
channel on-rate, of the CoChR appeared faster than ChR2 as indicated by their 
respective time to reach the peak current.  In contrast, the channel off rate (Toff) is 
slower for CoChR compared to that of ChR2. Thus, CoChR appears to be more efficient 
than ChR2 in conducting cation.  
Moreover, although the variant Chrimson could not generate as large current as 
others could, it can provide the basis for developing ChR with red spectral sensitivity 
and improved lower light sensitivity (operational light sensitivity). 
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Table 1: Comparison of the light response properties of ChR2, CoChR, and Chrimson (CnChR1) (Klapoetke 
et al., 2014). 
ChR 
Variants 
Peak Current 
Toff Time to 90% Ip λmax 
470 nm 530 nm 660 nm 
ChR2 479 pA 38 pA 0 14.59 ms ~6.0 ms 470 nm 
CoChR 3253 pA 1196 pA 0 86.03 ms ~4.5 ms 470 nm 
Chrimson 
(CnChR1) 
282 pA 432 pA 674 pA 22.40 ms ~7.0 ms 625 nm 
 
Shifting spectral sensitivity toward red 
Key structural determinants of ChR’s spectral properties 
In general, the spectral sensitivity of the chromophore ATR depends on: i) 
electrostatic interactions between protonated retinal Schiff base (RSBH+) and counter-
ions (Cis) that helps in stabilizing excited or ground state of the chromophore, ii) polarity 
around β-ionone ring and polyene chain of retinal, and iii) retinal distortion (Babitzki et 
al., 2009, Katayama et al., 2015). 
Earlier studies with ChR1 and ChR2 concluded that TM5 and TM6 are key 
regions for the wavelength sensitivity (Wang et al., 2009; Wen et al., 2010; Prigge et al., 
2012). In 2008, Zhang et al. identified genetically distinct ChR, from the algae Volvox 
carteri, with naturally red-shifted λmax at 535 nm and named it VChR1, as it was more 
related to ChR1. The four amino acid residues of VChR1, i.e. S176, L177, S178 and 
A251 (corresponding residues of ChR2; G181, L182, C183 and S256) were predicted to 
be critical for the red-shifted spectrum of VChR1. The first three are probably located 
near β-ionone ring of ATR, whereas A251 (of VChR1) is possibly near the nitrogen of 
the ATR polyene chain (Zhang et al., 2008). Noticeably, among the proposed amino 
acids, only serine (S) is the polar amino acid. Corresponding amino acid residues of 
ChR2 appeared to have polarity differences, e.g. S256 of ChR2 analogous to A251 of 
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VChR1. This indicated that polar and non-polar residues near ATR are important for 
spectral selectivity of ChRs.   
According to a recent report, the spectral difference of 30 nm between primate 
green and red sensitive pigments is solely due to presence of polar amino acids near 
the β-ionone ring (in case of red sensitive pigment) as there was no difference found in 
hydrogen bond networking among two pigments (Katayama et al., 2015). As described 
in following section, several attempts were made to change the spectral sensitivity of 
ChR2. 
Molecular engineering based ChR variants with altered Spectral sensitivity 
By systemic replacement of TMH regions between ChR1 and ChR2, Wang et al. 
(2009) concluded that TM5 and TM6 are important molecular determinants of ChR’s 
wavelength sensitivity, desensitization, and kinetics. In particular, they found that the 
N187Y mutation in TM5 region was one of the key determinants. In 2010, Wen et al. 
designed new variant ChRGR (ChR Green Receiver) by replacing TM1 and partial TM7 
(C terminus side) of ChR1 with those of ChR2. This ChRGR was shown to generate 
large current at long wavelength light (~520 nm), i.e. green light. By combining 
mutagenesis with chimera engineering approach, Lin et al., in 2013 successfully 
optimized a ChR variant with red-shifted λmax and named it ReaChR (Red activable 
ChR). This variant was founded on VChR1 and VChR2. Recently, the ReaChR has 
been shown to restore visual response in mouse models of retina degeneration (rd1), 
non-human primate (macaque) retina, and human’s post mortem retinas (of RP patients) 
(Sengupta et al., 2016). However, its poor sensitivity to dimmer light has remained 
unresolved.  
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In summary, molecular engineering approach is applicable to modify spectral 
properties of ChRs. Upon amino acid sequence alignment, it was noticed that some 
polar and non-polar residues are conserved in both ReaChR and Chrimson (two red 
light sensitive ChRs), while corresponding residues in both ChR2 and CoChRs (blue 
light sensitive) are of opposite polarities. These includes S86, M87, G161, I163 and 
S236 of the CoChR (Figure 5, red boxes), and it was hypothesized that polarity 
difference at these particular sites may influence the λmax of the CoChR. 
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Figure 5: Sequence alignment for ChR2-Wt, CoChR, ReaChR and Chrimson. Numbers above the 
sequence represents ChR2 amino acids numbering. To find analogous residues, relative amino acids 
numbering for other ChRs are mentioned in the respective parentheses on the left in each section. Based 
on ChR2, trans-membrane domains (TM ‘number’) are marked as black bars (with respective numbers) 
above the sequence. Amino acid residues before the TM1 belong to the amino (N) terminal, whereas 
those after the TM7 belong to the carboxyl (C) terminal end (Kato et al., 2012). Highlighted in blue boxes 
are ChR2 residues C128, L132C, D156 and T159C, and amino acids analogous to these were mutated 
for the CoChR and the ReaChR. Residues targeted for red spectral shift are highlighted in red boxes. 
Other residues targeted are highlighted in black box. 
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Significance  
ChR based optogenetic approach to restore vision in photoreceptor degenerative 
disease seems promising, and it is currently under phase I/II human clinical trial 
(ClinicalTrials.gov ID # NCT02556736) for evaluating optimal virus dosage and its 
safety concerns. Although the light sensitivity of ChR2 has been improved by molecular 
engineering, the ChR2-expressing RGCs are still at least three log units less light 
sensitive than cone photoreceptors (Figure 4). For retaining useful temporal resolution 
for the restored vision, the light sensitivity of the ChR2 could not be improved by further 
slowing its kinetics (Pan et al., 2014). Hence, ChRs with better conductance were 
needed. The newly discovered ChR variant CoChR has been shown to generate light 
response (photocurrent) larger than the ChR2-Wt, and its off-kinetics is fast compared 
to the most light- sensitive ChR2-L132C/T159S (Klapoetke et al., 2014). Therefore, 
there was a possibility of slowing CoChR’s off-kinetics (off rate), up to and within an 
optimal range of 200-1000 ms, to enhance its light sensitivity further. 
ReaChR has been shown to restore visual response in different RP models 
(Sengupta et al., 2016). Its red shifted λmax at ~530 nm (i.e. ~60 nm shift compared to 
ChR2) was emphasized as an advantage over ChR2. However, its sensitivity to low 
intensity light is poor. Thus, improving light sensitivity of ReaChR by molecular 
engineering was desired. Furthermore, ReaChR and Chrimson could provide the basis 
for developing highly light sensitive ChR variants with red-shifted spectrum. This study 
was aimed to develop more light sensitive CoChR and ReaChR variants by molecular 
engineering.
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CHAPTER 2: IMPROVING LIGHT SENSITIVITY OF CoChR 
Introduction: 
CoChR is a ChR variant from the algal species Chloromonas oogama (Co). It 
was shown to exhibit lager photocurrent than ChR2, suggesting that it has a higher 
single channel conductance (Klapoetke et al., 2014). The channel conductance 
determines the flux rate of ions across the channel upon its opening. Hence, a ChR with 
higher conductance can generate a lager photocurrent upon stimulation, which indicates 
its higher light sensitivity. However, increasing channel conduction for a ChR would be 
more challenging. Alternatively, the photocurrent of a ChR could also be increased by 
increasing its mean single channel open time. That is because the longer the time a 
channel remains open more the cations move into the cell. At the macroscopic level, 
this appears as a slower current kinetics or off-rate. The change in ChR’s kinetics by 
molecular engineering is more feasible by site-directed mutagenesis. In particular, 
despite its larger photocurrent, CoChR’s off rate (~112 ms) is faster than the previously 
optimized and most light sensitive ChR2 variant, ChR2-L132C/T159S (>1 s; Table 2). 
Therefore, CoChR’s operational light sensitivity could be further enhanced by slowing its 
kinetics via molecular engineering. 
Table 2: Comparison of light response properties of the wild type CoChR (CoChR-Wt) with that of 
the ChR2-Wt and its optimized variants. Data for ChR2 and its variants were taken from Pan et al., 
2014. Data presented as mean ± SEM. 
ChR Variants N Off-rate (ms) Peak Current (pA) 
  ND 0 ND 0 ND 2.5 
CoChR-Wt 10 112 ± 11 1468 ± 254 368.5 ± 44 
ChR2-Wt  7 18 ± 1 782 ± 84 26 ± 2.5 
ChR2-L132C/T159C 6 199 ± 17 1062 ± 11 212 ± 19 
ChR2-L132C/T159S 9 1090 ± 64 1037 ± 69 470 ± 34 
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Aim 1: Improving light sensitivity of CoChR via molecular engineering  
Rationale:  
 Many mutations in ChR2, C128T, D156A, L132C, L132A, T159C, T159S, and 
double mutants L132C/T159C, L132C/T159S, have been reported to slow down its off 
rate (Berndt et al., 2009; Pan et al., 2014).  Performing mutations at these 
corresponding sites in CoChR would be a logical starting point. For CoChR, the sites of 
L112, T139, C108 and D136 are analogues to the L132, T159, C128 and D156 of ChR2 
(see Figure 5). The L112 was mutated to A, C, D and S, the T139 to A, C and S, the 
C108 to A and T, and the D136 to A, C and T via site directed mutagenesis. These 
specific mutations at respective sites were chosen because similar mutations, at 
corresponding sites, have been shown to slower ChR2’s off-rate. Similarly, for CoChR 
too, these mutants were expected to slow down the off rate and consequently, for some 
of them, their current at lower light intensity might enhance.  
Next, upon amino acid sequence alignment, a possible endoplasmic reticulum 
(ER) retrieval signal sequence “KKXX” signal sequence, specifically “KKTK”, was 
observed in CoChR but not in the ChR2 (Figure 5 and 6A).  Such signal sequence can 
be recognized as two lysine (K) residues followed by any two amino acids (XX; hence 
KKXX). It can affect the protein trafficking and expression depending upon its position, 
which in turn may affect the functional properties it provides to the cell (Vincent et al., 
1998). Moreover, in the in-vitro cell culture of HEK cells, the membrane expression level 
of the CoChR was found to be significantly lower than that of ChR2 (Figure 6B). It was 
suspected to be an effect of “KKTK” signal sequence, hence, tested a hypothesis that 
interrupting such signal sequence via point mutation K264T (according to that of ChR2) 
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may improve CoChR’s membrane expression and consequently its light response 
properties.  
          
Figure 6: A likely ER-retrieval signal peptide in CoChR affecting its expression. A) Amino acids 
sequence alignment between ChR2 and CoChR (only respective portion of the report) showing presence 
of “KKTK” (KKXX) ER-retrieval signal peptide in CoChR, B) Expression level comparison between ChR2-
Wt and CoChR-Wt based on quantitative GFP fluorescence analysis. 
 
Recently, a positively charged amino acid arginine (R), specifically R88, has 
been shown to inhibit anion flux of the GtACR1, an anion ChR (ACR) from the algae 
Guillardia theta (Gt), emphasizing on the opposite charge inhibiting ion flux. Interestingly, 
CoChR also possess a positively charge amino acid histidine (H) at the corresponding 
site, i.e. CoChR-H94. The H94E (HE) mutation was created to test whether or not a 
negatively charged amino acid glutamic acid (E) inhibits cation influx of the CoChR. 
Additionally, it was tested in combination with L112C and K264T variants of the CoChR 
by creating H94E/L112C (HE/LC), H94E/K264T (HE/KT) and H94E/L112C/K264T 
(HE/LC/KT or 3Mt) mutants. To identify promising mutant variants, all variants were first 
screened for their off rate and current amplitude at low light intensity (ND2.5). Details of 
the methods and materials are described below. 
A B 
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Methods and Materials 
A) Molecular engineering to generate variants:  
The wild type CoChR gene sequence (Gene bank id # AHH02107.1) was 
synthesized (GeneScript, Piscataway, NJ, USA) and sub-cloned in the mammalian 
expression vector with CMV promoter to drive its expression (Figure 7). A single or 
multiple point mutations were created by site-directed mutagenesis (Quick Change 
Lightening, Agilent Technologies, Santa Clara, CA, USA). All the variants including wild 
type were fused with GFP at C’ which aided to track their expression and membrane 
trafficking. 
 
Figure 7: Schematic of the mammalian expression vector cassette showing cytomegalovirus 
promoter (CMV) driving expression of ChR fused with green fluorescence protein (GFP). 
B) HEK293f cell culture and transfection:  
The human embryonic kidney cells (HEK293f or HEK cells) were grown in 
Advance Dulbaco’s Minimum Essential Medium (DMEM; Life Technologies, Grand 
Island, NY, USA) supplemented with 1x MEM-non-essential amino acid solution and 5% 
Fetal Bovine Serum (FBS; Sigma Aldrich, St. Louis, MO, USA), and kept at 37°C with 5% 
CO2 humidified incubator. For transfection experiments, cells were seeded in 35 mm 
dish at the density of 5 x 105 cells/ml (3 ml per dish) and ATR was also added at final 
concentration of 1 µM. At about 48 hrs post-seeding, cells were transfected with 1µg of 
plasmid DNA carrying either wild type or mutant variant using lipofectamine reagent 
(Lipo2000; Life Technologies, Grand Island, NY, USA). 
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C) Expression levels quantification and patch clamp recordings: 
Expression level analysis and whole cell patch clamp recordings were performed 
at about 48 hrs post-transfection. The expression levels were quantified based on the 
GFP fluorescence in plasma membrane regions of the HEK cells. To measure GFP 
fluorescence, transfected HEK cells were fixed with 4% paraformaldehyde solution 
made in 0.1 M phosphate buffer (pH 7.2) for 10 minutes, followed by three washes with 
0.1 M phosphate buffer (pH7.2) for 10 min each, as previously described (Pan et al., 
2014). After washes, a drop of vectashield was applied and area was covered with 
cover slip. All the images were taken under similar settings (i.e. 400 ms light exposure 
time, 20x lens magnification) using Zeiss Axioplan2 microscope (Carl Zeiss) aided with 
the Apotome oscillating gratings to reduce out of–focus stray light. Single optical section 
images were used to calculate fluorescence intensity. The fluorescence intensity per 
pixel area of cell plasma membrane region was determined by ImageJ software as 
previously described (Pan et al., 2014). 
D) Whole cell patch-clamp recordings:  
Light response properties were obtained via whole cell patch clamp recording 
under voltage clamp (holding at -60 mV) conditions, as previously described (Pan et al., 
2014). The patch-clamp recordings were performed two days after plasmid DNA 
transfection. The chromophore ATR (1µM) was added to HEK cell growth medium at 
the time of seeding. All the recordings were done at room temperature, with EPC9 
amplifier and PULSE software (Heka Electronik, Laubrecht/pfalz, Germany). The glass 
electrodes were coated with a silicone elastomer (Dow Corning, Midland, MI, USA) and 
fire polished as previously described (Pan et al., 2014). 
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Extracellular solution (Hank’s balanced salt solution) for the recording contained 
(in mM): 138 NaCl, 1 NaHCO3, 0.3 Na2HPO4, 5 KCl, 0.3 KH2PO4, 1.25 CaCl2, 0.5 
MgSO4, 0.5 MgCl2, 5 HEPES, 22.2 glucose, pH 7.2. The electrode solution/internal 
solution (INS) contained (in mM): 130 K-Gluconate, 12 KCl, 1 MgCl2, 10 HEPES, pH 
7.2. ATR (1µM) was added to extracellular recording solution. A xenon lamp scanning 
monochromator (TILL photonics, Munich, Germany) was used to generate light of the 
wavelengths ranging from 350 nm to 700 nm, to stimulate transfected HEK cells. This 
light source was connected to the microscope via optical fiber. The different intensity of 
light stimuli was adjusted with neutral density (ND) filters. The light intensities relative to 
different ND filters are tabulated below where ND 0 means un-attenuated. 
Table 3:  Light intensities corresponding to the neutral density filters used. 
Filter position ND 
Light intensity (photons/cm2s) 
at 480 nm at 530 nm 
0 4.5 9.0 x 1013 8.6 x 1013 
1 4.0 2.3 x 1014 2.2 x 1014 
2 3.5 7.8 x 1014 7.4 x 1014 
3 3.0 9.7 x 1014 9.2 x 1014 
4 2.5 3.7 x 1015 3.5 x 1015 
5 2.0 1.3 x 1016 1.2 x 1016 
6 1.0 1.3 x 1017 1.2 x 1017 
7 0 8.9 x 1017 8.5 x 1017 
E) Data Analysis:  
The electrophysiology data were analyzed by PULSE software (Heka Electronik, 
Laubrecht/pfalz, Germany). Briefly, peak current (Ipeak) responses were measured from 
zero to the maximum level reached upon light stimulation, while the steady state levels 
(Iplateau) were measured at the end of the light pulse (Figure 8A). The off-rates were 
measured by fitting a single exponential function to the decaying phase of the current 
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evoked by 10 ms light pulse at ND0 (Figure 8B). Using Origin 6.1 software (OriginLab 
Corporation, Northampton, MA, USA), the independent t-test was performed to find any 
statistical difference.  
 
Figure 8: Typical photocurrent responses in ChR expressing HEK cell excited by a 1 s light pulse (A; 
blue bar) and 10 ms short light pulse (B; blue down arrow) measured at -60 mV by whole cell patch-clamp. 
In A, multiple current responses are at different light intensities. During light stimulation, at higher light 
intensity, current quickly reaches to the peak (Ipeak) and then decays to the steady state (Iplateau). The off 
rate obtained from the decaying phase of the current (generated with 10ms pulse) by applying single 
exponential function. 
Results: 
Initially, all the mutant variants of CoChR were evaluated for their expression, off 
rate and current amplitude to low light intensity at ND 2.5.  These results are 
summarized in Table 4. For the expression assessment, the CoChR-Wt’s expression 
level was considered as standard to grade the expression of mutant variants (Table 4). 
Relatively, for the CoChR variants L112C (LC), T139C (TC), LC-TC, C108A (CA), H94E 
(HE), L112C-K264T (LC-KT) and H94E-L112C-K264T (HE-LC-KT or 3Mt), the 
expression was comparable to the Wt, whereas the expression for the variant L112A 
(LA), L112S (LS), T139A (TA), T139S (TS) and H94E-L112C (HE-LC) was fairly good. 
The variant L112D (LD), C108T (CT), D136A (DA), D136C (DC), D136T (DT) and 
A B 
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H94E-K264T (HE-KT) expressed poorly. Exceptionally, the variant K264T expression 
appeared better than the Wt.  
 
 
 
Figure 9: CoChR variants screening for slowed off rate with improved current at ND 2.5. A) Off-
rates comparison. B) Current responses at lower light intensity (ND 2.5 = 3.7 x 10
15
 photons/cm
2
s) 
comparison. C) Current-kinetics relationship plot. Responses measured with 480 nm light pulses of 10ms 
for the off rate and 1 s for the current amplitudes. The “N” numbers are shown above the X-axis with 
respective bars in A and B. The mutants with off-rates too slow to be measured are marked with + sign in 
the section A. 
The off-rates and the current are also shown in Table 4. These properties were 
statistically compared with that of CoChR-Wt.  As shown in Figure 9A, the off rate 
significantly slowed for the mutants LC, LA, LS, TC, TA, TS, LC-TC, CT, HE, KT, HE-LC, 
LC-KT and HE-LC-KT (3Mt). Consequently, the current increased only for the LC, LA, 
C 
A B 
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KT, HE-LC and HE-LC-KT (3Mt) (Figure 9B). The mutant LA generated large current, 
but its off rate (~1400 ms) was slower beyond 1 s (Table 4). 
Table 4: Light response properties of CoChR variants; characterized in HEK293 cells by whole cell 
patch clamp recordings at 480 nm. Expression level grading; ▲▲▲▲ = good, ▲▲▲∆ = fairly good, 
▲▲▲ = fair, ▲▲∆ and ▲▲ = poor. Data are presented as mean ± SEM. ND0 = 8.9 x 10
17
 photons/cm
2
s, 
ND 2.5 = 3.7 x 10
15
 photons/cm
2
s. 
CoChR N Expression Off-rate (ms) Peak Current (pA) 
Variants  Full =▲, Half =∆ at ND 0 at ND2.5 
Wt 10 ▲▲▲▲ 112 ± 11 368.5 ± 44 
L112C (LC) 10 ▲▲▲∆ 372 ± 56 593 ± 91.5 
L112A (LA) 6 ▲▲▲ 1428.5 ± 169.5 707 ± 183 
L112D (LD) 5 ▲▲∆ too slow to be measured 34 ± 7 
L112S (LS) 3 ▲▲▲ 1433 ± 97 474 ± 72 
T139C (TC) 7 ▲▲▲∆ 292 ± 33 393 ± 77 
T139A (TA) 7 ▲▲▲ 2108.6 ± 449 452.5 ± 131.5 
T139S (TS) 6 ▲▲▲ 671.2 ± 59 354 ± 118 
LC-TC  6 ▲▲▲∆ 750.5 ± 101.5 577 ± 123 
C108A (CA) 3 ▲▲▲∆ too slow to be measured 152 ± 4.5 
C108T (CT) 3 ▲▲∆ 903 ± 180 52 ± 13.4 
D136A (DA) 3 ▲▲∆ too slow to be measured 9 ± 5 
D136C (DC) 3 ▲▲∆ too slow to be measured 39 ± 25.2 
D136T (DT) 2 ▲▲ too slow to be measured 12 ± 12 
K264T (KT) 10 ▲▲▲▲▲∆ 186 ± 18 640 ± 91 
H94E (HE) 10 ▲▲▲▲ 174 ± 13 388 ± 42.2 
H94E-L112C 
(HE-LC) 
10 ▲▲▲ 614 ± 46 618 ± 80 
H94E-K264T 
(HE-KT) 
11 ▲▲ 133 ± 12.5 212 ± 36 
L112C-K264T 
(LC-KT) 
13 ▲▲▲▲ 376 ± 37 516 ± 65.2 
HE-LC-KT (3Mt) 10 ▲▲▲∆ 723 ± 71 955 ± 87.4 
For all these mutants, the off-rates were plotted against their respective currents 
(Figure 9C). The variants LC, KT, HE-LC and HE-LC-KT (3Mt) appeared to be 
potentially useful because they exhibited enhanced current with their slowed off rate 
within 1 s. Among these mutants, H94E-L112C-K264T (3Mt) exhibited the largest 
current. Therefore, CoChR-3Mt could be a best optimized and the most sensitive variant 
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of CoChR. This CoChR-3Mt (HE-LC-KT) together with its related mutants, i.e. HE, LC, 
KT, HE-KT, HE-LC and LC-KT, were chosen for further characterization. The results are 
described below. 
A) Expression level analysis and primary screening of CoChR variants: 
The expression of these seven CoChR mutants and of CoChR-Wt was quantified 
based on the GFP fluorescence intensity in plasma membrane region of HEK cells. A 
representative fluorescence image of HEK cell expressing different CoChR variants is 
shown in Figure 10A. Comparison of fluorescence intensities (arbitrary fluorescence 
intensity per unit area; AFU/pixel2) are shown in Figure 10B. There was no significant 
difference in the expression between CoChR-Wt and LC, HE, LC-KT, and 3Mts (Figure 
10B). The expression of two mutants, HE-KT and HE-LC, however, was significantly 
lower (~47% and ~25% respectively) than CoChR-Wt. On the other hand, the 
expression of K264T (which was targeted to interrupt “KKXX” signal sequence) was 
significantly higher (~51% better) compared to CoChR-Wt. 
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Figure 10: Expression level comparison in HEK293 cells; A) Representative image of HEK293 cell 
expression of CoChR-Wt and its variants L112C (LC), K264T (KT), H94E (HE), HE-KT, HE-LC, LC-KT 
and 3Mts (HE-LC-KT). Scale bar 20 um. B) Mean fluorescence intensities measured in plasma 
membrane region and represented as arbitrary fluorescence unit per pixel area (AFU/pixel2) ± SEM. The 
cell numbers (n) are shown in respective bars. 
A 
B 
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B) Characterization of light response properties of selected CoChR variants in 
HEK293 cells:  
The light response properties of these selected mutants were examined and 
compared with CoChR-Wt. Their spectral curves were found unchanged, with a λmax of 
480 nm (Figure 11). Therefore, all of the further characterizations were conducted with 
480 nm light stimulation. Statistical data in comparison of their response properties, 
including off-rates and current amplitudes are shown in Table 5. 
 
Figure 11: Spectral curve comparison for CoChR variants. Responses to each wavelength (from 400 
nm to 560 nm) were recorded under voltage clamp conditions (-60 mV) at ND 2.5.  Average of three 
responses was taken to plot the curve for each variant. ND 2.5 = 3.7 x 10
15
 photons/cm
2
s. 
The representative current traces in response to 1 s light pulse with incremental 
light intensities are shown in Figure 12. For all the CoChRs, during 1s light stimulation 
at the higher light intensities, the current quickly reached to a peak and then decayed to 
a steady state, which is caused by channel desensitization. The steady state current is 
referred as plateau current. Overall, the current amplitudes were light intensity 
dependent (Figure 13A and B). Statistically, the peak currents at ND 0 for all seven 
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mutants were not significantly different from that of CoChR-Wt (Table 5 and Figure 13C). 
On the other hand, the peak current for CoChR-HE/KT was significantly lower than that 
of CoChR-KT and CoChR-3Mt. The level of desensitization for all mutants except 
HE/KT was reduced in comparison to CoChR-Wt, which resulted in relatively larger 
plateau currents (Figure 13B). Therefore, although the peak currents were not 
significantly different for any of the selected variants, the ratios of plateau to peak 
currents were significantly higher for all mutants except HE/KT (Table 5, Figure 13D). 
This ratio was especially high for LC, HE-LC, LC-KT and 3Mt. 
Table 5: Light response properties of selected CoChR variants; characterized in HEK293 cells by 
whole cell patch clamp recordings at 480 nm. Data presented as mean ± SEM. ND0 = 8.9 x 10
17
 
photons/cm
2
s, ND 2.5 = 3.7 x 10
15
 photons/cm
2
s. 
CoChR 
Variants 
N 
Off rate 
(ms) 
Current (pA) Current ratios 
  ND 0 ND 0 ND 2.5 IPlateau/Ipeak ND2.5/ND0 
Wt 10 112 ± 11 1465 ± 25 368.5 ± 44.25 0.4 0.25 
L112C (LC) 10 372 ± 56 1437 ± 22 593 ± 91.47 0.8 0.4 
H94E (HE) 10 174 ± 13 1286 + 11 389 ± 42.17 0.5 0.3 
K264T (KT) 10 186 ± 18 2182 ± 30 640 ± 90.70 0.5 0.3 
HE/KT 11 133 ± 12.5 917 ± 11 212 ± 35.88 0.4 0.2 
HE/LC 10 614 ± 46.2 1229 ± 15 618.2 ± 80.43 0.8 0.5 
LC/KT 13 376 ± 37 1238 ± 15 516 ± 65.16 0.8 0.4 
HE/LC/KT 
(3Mt) 
10 723 ±71 1614.5 ± 13 955 ± 87.37 0.9 0.6 
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Figure 12: Representative current traces mediated by CoChR and its variants in HEK293 cells. 
Responses were generated under voltage clamp (-60 mV) conditions with 1 second (480 nm) light 
stimulation. Light intensities were attenuated by neutral density filters ND 4.5, 4, 3, 2.5, 2 and 1. Blue 
line/bar on top represents duration of light stimulation. 
 
A B C 
D E F 
G H 
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Figure 13: Light intensity response curves of CoChR variants; peak (A) and plateau (B) currents 
were obtained in response to different light intensities of 480nm. The data are presented at mean + SD. 
Photocurrent response comparison; C) Peak current at brightest light, i.e. ND 0, D) Plateau to peak 
current ratio representing degree of peak current desensitization. ND0 = 8.9 x 10
17
 photons/cm
2
s, ND 2.5 
= 3.7 x 10
15
 photons/cm
2
s. 
Figure 14 summarizes the relationship between current amplitudes and off-rates 
for all these CoChRs. The off-rates were calculated by fitting a single exponential 
function to the decaying phase of the currents evoked by a 10 ms light pulse at ND 0 
(Figure 14A). The off-rates for the variant LC, HE, KT, HE/LC, LC/KT, and 3Mts were 
significantly slower than CoChR-Wt (Figure 14A and B). Again, the 3Mts was the 
slowest. The mean peak currents at ND 2.5 light intensity with the level of significant 
differences are shown in Figure 14C. For the variant LC, KT, HE-LC, and 3Mt current at 
ND 2.5 increased significantly compared to CoChR-Wt, which indicated their enhanced 
C 
A B 
D 
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operational light sensitivity. Such increased response to lower light intensity was 
superior for the 3Mts. These enhancements can also be clearly noticed by comparing 
responses represented in red lines in the earlier Figure 12. Evidently, the 3Mts 
generated significantly highest current (at ND 2.5) among all. To determine the 
relationship between slower off-rates and improved operational light sensitivity, the 
mean peak currents at lower light intensity (ND 2.5) were plotted against their 
respective off-rates (Figure 14D). The trend line in the graph indicates a linear 
relationship for all the variants, which supports the hypothesis of slowing the off rate to 
improve operational light sensitivity of CoChR. 
Higher currents at lower light intensity (ND 2.5) might be due to the overall larger 
(maximum) current at the brightest light (ND 0). The ratio of current at these two light 
intensities (ND 2.5/ND 0) indicates the percentage of maximum current generated at 
lower light intensity. Such ratio distinguishes variant(s) with truly improved operational 
light sensitivity. For instance, a variant CoChR-K264T generated current comparable to 
CoChR-L112C at lower light intensity (640 ± 90.7 pA and 593 ± 91.5 pA respectively; 
refer Table 5), but its ratio to the maximum current, i.e. at ND 0, is not significantly 
different than the wild type CoChR (Figure 14E). On the contrary, such ratio for a variant 
CoChR-L112C is significantly higher than wild type CoChR. This implies that the 
CoChR-L112C have truly improved operational light sensitivity in contrast to the 
CoChR-K264T. Other variants with significantly higher ND2.5/ND 0 current ratio include 
HE/LC, LC/KT and HE/LC/KT (3Mts). Evidently, for the 3Mts variant this ratio was the 
highest (59%) and significantly higher than both the CoChR-Wt (25%) as well as the LC 
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(41%). Thus, the operational light sensitivity of the 3Mt variant was improved 34%, i.e. 
from 25% (Wt) to 59% (3Mts).  
        
       
      
Figure 14: Kinetic properties of CoChR variants characterized in HEK293 cells. A) Representative 
traces of 10 ms pulse (ND 0) stimulation, for different variants, to compare off kinetics (deactivation). B) 
Mean off-rates (deactivation time constant) comparison. These deactivation time constants were obtained 
by fitting a single exponential function to the decaying phase of the current evoked by 10 ms pulse at ND 
0, as shown in A. C) Comparison of mean peak currents at ND 2.5 (low light intensity), elicited with 1 
second light pulse of 480 nm. D) The relationship plot between the off-rates and the peak current at low 
C 
A B 
D 
E F 
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light intensity (ND 2.5) , E) ND 2.5 to ND 0 current ratio representing light sensitivity in terms of 
percentage of maximum current generated, F) Peak current normalized to respective cell capacitance, at 
ND 0.Data presented as mean + SEM error bars. The “n” numbers are indicated in white box over the top 
of the X-horizon at their respective bars. ND0 = 8.9 x 10
17
 photons/cm
2
s, ND 2.5 = 3.7 x 10
15
 
photons/cm
2
s. 
Figure 14F shows the peak current normalized to the capacitance, which 
represents the current density. The current density correlates with the number of 
channels on cell surface (expression level), channel open time, and single channel 
conductance. Consistent with the observed higher expression level of the variant 
CoChR-KT, current density (pA/pF) was found to be significantly higher compared to 
CoChR-Wt (Figure 14F). Such current density was also significantly higher for the 
CoChR-3Mt, which is consistent with its longer channel open time since its expression 
level was not different from CoChR-Wt (see Figure 10B). 
Since the magnitude of the current generated was light intensity dependent, a 
dosage response curve was generated to obtain the threshold light intensity required to 
generate half-maximum current (Ip50). It is referred to as effective power density for 50% 
activation (EPD50), which is similar to the EC50 (Mattis et al., 2012). Such dose 
response curve shifted leftward for all variants compared to that of the CoChR-Wt 
(Figure 15A). Especially for the 3Mt variant, it was the most leftward shifted, and its 
EPD50 was lowest among all (Figure 15B), which is consistent with its higher 
operational light sensitivity. Moreover, the EPD50 and the off rate were highly correlated 
(Figure 15C), suggesting that the off rate contributed to higher operational light 
sensitivity which is again consistent with proposed hypothesis. 
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Figure 15: Light sensitivity comparisons between CoChR variants. A) Dosage response curve 
generated using nonlinear least square fitter function; y(x) = {A1-A2/1+(x/x0)
p
} + A2, where A1 = initial y 
value, A2 = final y value, x0 = center value, p = power. B) EPD50, i.e. effective power density to generate 
half-max current. C) EPD50 vs off rate (± SEM) relationship plot. 
Conclusion: 
For the first time to the best of my knowledge, I have identified two additional 
sites and specific mutations, i.e. H94E and K264T, which together in combination with 
L112C mutation (i.e. CoChR-HE-LC-KT), further enhanced the operational light 
sensitivity of CoChR (beyond the CoChR-L112C). This newly engineered variant 
CoChR-3Mts (CoChR-HE-LC-KT) has promise to be a better optogenetic tool for the 
ChR based optogenetic approach to restore vision. 
C 
A B 
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Discussion:  
For improving light sensitivity of CoChR, mutations were introduced at amino 
acid sites L112, T139, C108, and D136, corresponding to the L132, T159, C128 and 
D156 of ChR2. Except for the mutants L112C and L112A, all of these either showed 
poor expression in HEK cells or no significant improvement in current at ND 2.5 light 
intensity as a consequence of slower off-rate. However, the off rate of the variant L112A 
was above the anticipated 1s limit.  
Additionally, a point mutation variant K264T (KT), interrupting a likely ER-retrieval 
signal sequence of CoChR, was tested. Evidently, the KT variant had higher current 
density (pA/pF) owing to its superior expression level in the plasma membrane. It 
showed significantly enhanced expression level with little slower off-rate, which together 
contributed to its higher photocurrent at lower light intensity (ND 2.5). However, this was 
not considered as increased operational light sensitivity since the current ratio of 
ND2.5/ND0 was not significantly higher than that of the CoChR-Wt. Such a ratio helps 
to segregate the mutants with improved operational light sensitivity from those with 
improved protein expression. 
Another mutant variant H94E was created to test whether or not a negatively 
charged amino acid E (at the site H94) can inhibit cation influx of CoChR. In addition to 
the CoChR-Wt, two of its variants L112C and K264T were also tested for H94E 
mutation effect. No cation inhibition was found since all the variants carrying the H94E 
mutation, i.e. HE alone, HE-LC, HE-KT and HE-LC-KT (3Mts), were fully functional. 
Moreover, the triple mutant variant HE-LC-KT (3Mts) was found to be the most light-
sensitive CoChR variant reported to date. This 3Mts variant exhibited slower off rate as 
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well as the least of current desensitization. These properties together contributed to its 
highest current, especially at low light intensity, implying its higher operational light 
sensitivity.  
Differences in intrinsic light sensitivity of the channel, off kinetics or both can 
cause differences in EPD50, also referred to as population light sensitivity (Mattis et al., 
2012). The intrinsic light sensitivity of the channel is simply the efficiency with which an 
individual channel gets activated by light (Sugimaya et al., 2009). For the selected 
CoChR variants, their operational light sensitivity was found to be correlated with 
slowed off-rates, and this is consistent with proposed hypothesis. 
Overall, the CoChR-3Mt was identified as an optimized and most light sensitive 
ChR variant for several reasons based on data obtained. First, its expression and 
membrane trafficking was as good as CoChR-Wt. Second, it generated largest current 
at lower light intensity, implying its highest operational light sensitivity. Third, its slower 
off rate was still within the anticipated limit of 1 second, and hence, it can be expected 
to render suitable temporal coding ability to CoChR-3Mts expressing RGCs in-vivo. 
Fourth, it showed lowest EPD50 indicating its higher operational light sensitivity.
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CHAPTER 3: IMPROVING LIGHT SENSITIVITY OF ReaChR 
Introduction:  
Since current ChR based optogenetic vision restoration requires supremely high 
intensity light stimulation (>1016 photons/cm2 s), the longer wavelength light (red light) is 
considered safer (at such high intensity) than the shorter wavelength light (blue light). 
ReaChR is a chimera of two different ChRs, VChR1 and VChR2, from the algal species 
Volvox carteri, developed by Lin et al. in 2013. Its peak spectral sensitivity was 
observed at 530 nm which is 60 nm red shifted than that of ChR2 (470 nm), and this is 
an advantage over using blue light sensitive ChRs in general. It has been shown to 
restore visual response in mouse model of retinal degeneration (rd1), macaque retina 
and post mortem retinas of RP patients (Sengupta et al., 2016). However, the 
responses were evoked only at the higher light intensity (>1015 photons/cm2s; 590 nm) 
and no further efforts were made to improve operational light sensitivity of the ReaChR. 
Such a high intensity was described to be safer (for the retina tissue) only because of 
the red spectral sensitivity (at 590 nm) of the ReaChR compared to that of the ChR2. 
Therefore, the development of the ReaChR variant with enhanced operational light 
sensitivity was desired.  
Based on its light response properties in HEK cells, the ReaChR appears to be 
equally efficient as ChR2 (Table 6, Figure 16).  For instance, the ReaChR generated 
lager current at low light intensity (ND2.5) than that of the ChR2-Wt and ChR2-
L132C/T159C owing to its slower off rate. The current-kinetics relationship curve further 
clarifies it as the data point of ReaChR followed the relationship line of ChR2 (Figure 
16). Hence, the operational light sensitivity of ReaChR could be improved by slowing its 
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kinetics via molecular engineering approach. Such optimized variant(s) will have an 
additional advantage of red-shifted peak spectral sensitivity. 
Table 6: Comparison of light response properties of wild type ReaChR (ReaChR-Wt), ChR2 and its 
optimized variants. Data for ChR2 and its variants (tested at 460nm) are taken from Pan et al. 2014. 
Data are presented at mean ± SEM. ReaChR tested at 530nm. For 530nm ND0 = 8.5 x 10
17
 
photons/cm
2
s, ND 2.5 = 3.5 x 10
15
 photons/cm
2
s. 
ChR variants N Off-rate (ms) Peak current  (pA) 
  ND 0 ND0 ND2.5 
ReaChR-Wt 10 414 ± 28 782 ± 69 291 ± 23 
ChR2-Wt 7 18 ± 1 782 ± 84 26 ± 2.5 
ChR2-L132C/T159C 6 199 ± 17 1062 ± 11 212 ± 19 
ChR2-L132C/T159S 9 1090 ± 64 1037 ± 69 470 ± 34 
 
 
Figure 16: Comparison of current-kinetics relationship of ReaChR and ChR2 variants. 
Aim2: Improving light sensitivity of ReaChR via molecular engineering. 
Rationale:  
Slowing channel’s off-kinetics has been reported to increase operational light 
sensitivity of the ChR2 (Pan et al., 2014). A possible reason is that the longer the time a 
channel remains open more the cations move into the cell which is estimated as larger 
current amplitude. An example includes ChR2 mutants C128T, D156A, L132C, L132A, 
T159C, T159S, and double mutants L132C/T159C and L132C/T159 (Berndt et al., 2009; 
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Pan et al., 2014). In addition to the slower off rate, the ChR2-L132C mutant also 
showed reduced desensitization and increased Ca++ ion permeability contributing to its 
larger plateau photocurrent (Prigge et al., 2012). It was hypothesized that corresponding 
mutations in the ReaChR may result in similar gain. For the ReaChR, the amino acids 
L172, C199, C168, and D196 were corresponding to the ChR2-L132, T159, C128, and 
D156, respectively (see Figure 5), and they were mutated accordingly. Briefly, the L172 
was mutated to “A”, “S”, “C” and “D”; the C199 was mutated to ‘A’, ‘S’ and ‘G’; the C168 
was mutated to ‘A’ and ‘T’; the D196 was mutated to ‘C’ and ‘T’. These specific 
mutations at respective sites were chosen because similar mutations, at corresponding 
sites, have been shown to slower ChR2’s off rate (Berndt et al., 2009; Pan et al., 2014). 
Similarly, it was hypothesized that corresponding mutants of ReaChR might slow down 
its off rate and consequently some of them also improve current response at lower light 
intensity. Hence, primarily all these mutant variants were screened for their off rate 
kinetics and current level in response to low light intensity (ND 2.5) via whole cell patch 
clamp recordings. 
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Figure 17: Schematics of chimeras ReaChR and #24 (and their constituent ChRs) showing 
difference in their respective trans-membrane domains TM1, TM6 and TM7. 
Next, ReaChR was compared with one of the designed chimera #24 
(unpublished preliminary data), which has spectral property similar to the ReaChR. As 
shown in the Figure 17, the ReaChR and the chimera #24 have differences in the TM1, 
TM6 and TM7. In these regions, 16 sites differences (as shown in black boxes 
individually for ReaChR in Figure 5) were selected for performing mutation. These sites 
were chosen because most of them have identical amino acids between ChR2 and 
CoChR. The goal was to find mutations among these sites to enhance the operational 
light sensitivity of ReaChR. Therefore, logically first ReaChR residues V98, V99, V104, 
A105, G108, W109, A114, A117, L247, L251, R253, V268, M299, V302, N305 and 
K310 were mutated according to matching CoChR residues to generate V98I/V99T, 
V98F/V99G, V104I/A104L, G108M, G108I/W109Y, A114T, A117S, L247R, 
47 
 
 
 
L251V/R253T, V268I, M299C, V302L, N305H, V302L/N305H and K310E variants of the 
ReaChR. Upon preliminary screening of these ReaChR mutants, two new sites V302 
and N305 were identified as potential new targets in addition to sites corresponding to 
the L132, T159, C128 and D156 of the ChR2. Hence, additional mutations were created 
at these two sites, which included V302A, V302M, V302C, V302I, V302S, N305A, 
N305R, N305C, N305D, N305W, V302L-N305C and V302M-N305C. 
Next, the site I171 was chosen to mutate since it was originally mutated from 
L171 to I to increase photocurrent amplitude of a precursor variant of the ReaChR (Lin 
et al., 2013). Briefly, the residue I171 was mutated to M, A, C, S, N and T. Additionally, 
the mutation I171M was combined with a double mutant V302L/N305H to optimize the 
slower off rate within the anticipated limit of 1 s, and thus the triple mutant variant 
ReaChR-I171M/V302L/N305H (3Mt) was generated. 
Additionally, the site N154 corresponding to CoChR-H94 was mutated to E, 
similar to CoChR-H94E. It was also mutated to C and in combination with its 
neighboring site G155 to create N154C and N154H/G155R (respectively based on 
ChR2-H114/R115, see Figure 5). As described earlier for the CoChR, for all of ReaChR 
mutants, their expression level, off rate and peak current at low light intensity (ND2.5) 
were checked via whole cell patch clamp recording. Since, these mutations were aimed 
to slow the off rate and consequently improve the current at low light intensity, any 
variant which did not fulfill this expectation were excluded from further detailed 
characterization.  
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Methods and Materials 
Same as described for CoChR in the aim-1 section (see pages 26-29), except 
that the wavelength of the light used was 530 nm. 
Results:  
A) Targeted mutations at the sites corresponding to the ChR2 
The results of the expression quality, off-rate, and the current amplitude to a low 
light intensity (ND 2.5) are tabulated in Table 7. Although the off rate of the mutants 
L172C, L172A, L172S, and C199A slowed significantly, it did not improve their current 
responses at low light (Figure 18). In fact, none of the mutants targeted to the amino 
acids L172, C199, C168, and D196 sites showed the increase in current (Figure 18B). 
On the contrary, the off rate for the mutants C199G, C168A, and C168T was 
accelerated which in turn reduced their current, except for C168A, which remained 
unaffected. 
       
Figure 18: Primary screening of ReaChR variants for slowed off rate with improved current at ND 
2.5. A) Mean off-rates (deactivation time constant) comparison. These deactivation time constants were 
obtained by fitting a single exponential function to the decaying phase of the current evoked by 10 ms 
pulse at ND 0. B) Comparison of mean peak currents at ND 2.5, elicited with 1 second light pulse of 530 
nm. ND 2.5 = 3.5 x 10
15
 photons/cm
2
s. 
A B 
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Table 7: Light response properties of ReaChR variants (part-1); characterized in HEK293 cells by 
whole cell patch clamp recordings at 530 nm. Expression level grading; ▲▲▲▲ = good, ▲▲▲∆ = fairly 
good, ▲▲▲ = fair, ▲▲∆ and ▲▲ = poor. Data are presented as mean ± SEM. ND0 = 8.5 x 10
17
 
photons/cm
2
s, ND 2.5 = 3.5 x 10
15
 photons/cm
2
s. 
ReaChR N Expression Off-rate (ms) Peak Current (pA) 
Variants  Full =▲, Half =∆ ND 0 ND2.5 
  Aggregations = *   
ReaChR-Wt 11 ▲▲▲▲ 414 ± 28 291 ± 23 
L172C 5 ▲▲▲▲ 1856 ± 281 118 ± 22.3 
L172A 6 ▲▲▲ 1522 ± 95 77 ± 7 
L172S 6 ▲▲▲ 1328 ± 122 76 ± 13 
L172D 2 ▲ No current No current 
C199A 6 ▲▲▲▲ 1653 ±124.22 293.4 ± 64.5 
C199S 6 ▲▲▲▲ 342.5 ± 22 166 ± 26.3 
C199G 7 ▲▲▲ 90 ± 6.5 32 ± 9 
C168A 6 ▲▲▲▲ 299 ± 21.5 208 ± 46 
C168T 3 ▲▲▲▲ 266 ± 22 17 ± 1 
D196C 4 ▲▲▲ No current No current 
D196T 1 ▲▲∆ No current No current 
 In summary, mutations at the sites corresponding to the ChR2 mutants failed to 
improve the operational light sensitivity of ReaChR. This suggested that the amino acid 
residues involved in ReaChR’s ion conduction pathway differer from those of ChR2. 
Therefore, finding different target sites that can slow its kinetics was desired. 
B) Targeted mutations based on the chimera #24: 
Firstly, mutant variants at 16 different sites were screened for differences in off 
rate and peak current. The ReaChR mutants G108I/Y109W, V302L, N305H, and 
V302L/N305H were found to slow the off rate significantly (Figure 19A). Among them, 
the double mutant V302L/N305H (VL/NH) exhibited an increase in the current 
significantly (Figure 19B). Although the current increased for the variant VL/NH, its off 
rate (~1.67 s; Table 8) appeared to be too slow for optogenetic vision restoration. 
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Nevertheless, the results identified the mutations V302L and N305H that were able to 
slow the kinetics and improve the current. Additional mutations were created at these 
two sites to find better ReaChR variant. 
An alternative approach was to combine the VL/NH mutant with additional 
mutations to accelerate its off rate to within one second. One such mutation was I171M. 
Therefore, the triple mutant of I171M/V302L/N305H (IM/VL/NH or 3Mt) was created. 
Furthermore, these three sites (I171, V302 and N305) were explored with different 
amino acid replacements, and their combinations (Figure 19). Among these, the 
mutation I171M upon combining with VL/NH accelerated its off rate from ~1.7 s to ~900 
ms (Table 8), i.e. within the limit of 1 s. Also as expected, the acceleration of the off rate 
of the 3Mt reduced its current amplitude in compared to VL/NH; however, the current 
was still significantly larger than that of wild type ReaChR (Figure 19B). 
The 3Mts (IM/VL/NH) generated the best performance among all of the mutations 
tested (Figure 19, Table 8). Moreover, none of the additional mutations of 3Mts 
improved its light response property. Thus, in summary, two sites V302 and N305 were 
identified, which improved the light sensitivity of ReaChR. In particular, two mutant 
variants, ReaChR-VL/NH and ReaChR-3Mts, with improved operational light sensitivity 
were found. ReaChR-3Mts was characterized further because of its optimized kinetics 
and improved light sensitivity. 
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Figure 19: Primary screening of additional ReaChR variants for slowed off rate with improved 
current at ND 2.5. A) Mean off-rates (deactivation time constant) comparison. These deactivation time 
constants were obtained by fitting a single exponential function to the decaying phase of the current 
evoked by 10 ms pulse at ND 0. B) Comparison of mean peak currents at ND 2.5, elicited with 1 s light 
pulse of 530 nm. ND 2.5 = 3.5 x 10
15
 photons/cm
2
s. 
A 
B 
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Table 8: Light response properties of additional ReaChR variants (part-2); characterized in HEK293 
cells by whole cell patch clamp recordings at 530 nm. Expression level grading; ▲▲▲▲ = good, 
▲▲▲∆ = fairly good, ▲▲▲ = fair, ▲▲∆, ▲▲ = poor, and * = aggregations. ND0 = 8.5 x 10
17
 
photons/cm
2
s, ND 2.5 = 3.5 x 10
15
 photons/cm
2
s. 
ReaChR N Expression Off-rate (ms) Peak current (pA) 
Variants  Full =▲, Half =∆ ND 0 ND2.5 
ReaChR-Wt 11 ▲▲▲▲ 414 ± 28 291 ± 23 
V98I-V99T 4 ▲▲▲∆ 230 ± 19 148 ± 50 
V98F-V99G 3 ▲▲▲∆ 162 ±16.5 61.5 ± 21 
V104I-A105L 3 ▲▲▲ 322 ± 18 151 ± 6.5 
G108M 3 ▲▲▲∆ 374 ± 43 93 ± 8.6 
G108I-W109Y 4 ▲▲▲▲ 1193 ± 297 277.4 ± 64 
A114T 2 ▲▲▲∆ 505 ± 24 261 ± 130 
A117S 3 ▲▲▲▲ 548 ± 58 270 ± 95 
L247R 8 ▲▲∆ 425 ± 32 178 ± 24 
L251V-R253T 8 ▲▲▲ 434 ± 38 167.4 ± 22.3 
V268I 5 ▲▲▲ + *  269 ± 13 139 ± 14 
M299C 4 ▲▲▲∆ + * 540 ± 47 144 ± 18.4 
V302L 4 ▲▲∆ + * 554 ± 73 374.4 ± 122 
V302A 4 ▲▲▲▲ 467 ± 64 180.4 ± 37.5 
V302M 7 ▲▲▲∆ 345 ± 53 266.5 ± 32 
V302C 3 ▲▲▲∆ 204 ± 6 150.5 ± 13.6 
V302I 4 ▲▲▲▲ 384 ± 14 237 ± 51 
V302S 3 ▲▲▲+ * 369 ± 49 250 ± 90 
N305H 7 ▲▲▲∆ 1796 ± 160.4 348.5 ± 37.2 
N305A 3 ▲▲▲∆ 1320 ± 114 297 ± 55 
N305R 4 ▲▲∆ 1389 ± 334 180 ± 67.5 
N305C 8 ▲▲▲∆ 744 ± 32 323 ± 28 
N305D 7 ▲▲▲ 1182 ± 134 343.6 ± 32 
N305W 3 ▲▲▲∆ 269 ± 29 226 ± 95.6 
V302L-N305H 7 ▲▲▲∆ 1665.71 ± 304.55 624.36 ± 131.11 
V302L-N305C 8 ▲▲▲∆ 1351.67 ± 38.25 290.13 ± 47.82 
V302M-N305C 7 ▲▲▲∆ 1508.00 ± 191.19 377.60 ± 47.71 
I171M 7 ▲▲▲ 116.23 ± 7.94 142.01 ± 29.38 
I171A 4 ▲▲▲∆ 26.53 ± 1.01 19.19 ± 7.91 
I171C 3 ▲▲▲ 26.90 ± 4.02 15.85 ± 8.29 
I171S 4 ▲▲▲∆ 40.95 ± 1.36 18.15 ± 6.40 
I171N 1 Toxic 31 ± 0.0 10.4 ± 0.0 
I171T 4 ▲▲▲▲∆ 450 ± 42.5 166 ± 28 
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Table 8 continued…! 
I171V 3 ▲▲∆ 167 ± 29 127 ± 56 
IM-VL-NH (3Mt) 11 ▲▲▲▲ 935 ± 133.5 385 ± 24 
3Mts-K324T 4 ▲▲▲ 979.5 ± 44 201 ± 35 
3Mts-A114T 6 ▲▲▲ 592 ± 26 292 ± 66.5 
3Mts-A117S 6 ▲▲▲ 828 ± 45.5 352 ± 35.4 
3Mts-N154E 6 ▲▲▲▲ 1223 ± 70 451 ± 54 
K310E 10 ▲▲∆ 320 ± 14.5 130 ± 16 
N298E 6 ▲▲▲∆ 356.5 ± 34.5 70.5 ± 15.4 
K324T 5 ▲▲▲▲ 537 ± 69 271.3 ± 91 
N154E 6 ▲▲▲+ * 411 ± 34.5 380.4 ± 73.5 
N154C 3 ▲▲▲∆ 393 ± 70 171 ± 37 
N154A 4 ▲▲▲ 452 ± 45 269 ± 77 
N154H-G155R 3 ▲▲▲+ * 207 ± 5 70 ± 18 
G108M-V302L 2 ▲▲▲ 315 ± 40 127 ± 23 
A117S-V302L 3 ▲▲▲∆ 603 ± 54 299 ± 60.4 
N154E-V302L 3 ▲▲▲ 410 ± 70 176 ± 52 
A114T-N305C 3 ▲▲▲▲ 576 ± 34 149.6 ± 52 
A117S-N305C 3 ▲▲∆ 1563 ± 474 162 ± 8 
G108M-N154E 3 ▲▲▲∆ 280 ± 23 120 ± 13 
A114T-N154E 4 ▲▲▲∆ 467 ± 52 156 ± 25 
A117S-N154E 3 ▲▲▲ 540 ± 39 265 ± 35 
C) Characterizing the optimized variant ReaChR-3Mts (IM-VL-NH) in HEK cells. 
First, ReaChR-3Mts’s expression in HEK cells was compared with that of 
ReaChR-Wt. The representative images of HEK cell expressing wild type and 3Mts are 
shown in Figure 20A. There was no statistical difference found in quantified level of 
mean fluorescence intensity (AFU/Pixel2) of these two (Figure 20B). 
The light response properties were characterized in HEK cells with whole cell 
patch clamp recordings. The peak spectral sensitivity and the overall spectral curve for 
the ReaChR-3Mt variant shifted towards blue with the peak at around 500 nm compared 
to 530 nm of the wild type ReaChR (Figure 21A). However, for the comparison purpose 
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all the characterization was done with 530 nm light. The representative current traces in 
response to light with incremental intensity stimulation are shown in Figure 21B and C. 
 
                        
Figure 20: Expression level comparison in HEK293 cells. A) Representative image of HEK293 cell 
expression of ReaChR-Wt and its variant 3Mt (I171M-V302L-N305H). Scale bar 20 um. B) Mean 
fluorescence intensities measured in plasma membrane region, and it is represented as arbitrary 
fluorescence unit per pixel area (AFU/pixel
2
) ± SEM. The numbers (n) are shown in respective bars. 
The values of the current responses and the kinetics are summarized in Table 9. 
For the ReachR-3Mt, the peak current at the highest light intensity (ND 0) observed was 
842 ± 57, which is higher but not significantly different than that of the wild type ReaChR 
(782 ± 69) (Figure 22A). The level of peak current desensitization was reduced to 33% 
for the 3Mt compared to 45% of the wild type. This is represented in Table 9 as a ratio 
of plateau current (IPla) and peak current (IP), and this ratio for 3Mt variant is significantly 
higher than that of the wild type ReaChR (Figure 22B). Overall, the current responses 
were light intensity dependent and the reduced desensitization contributed to higher 
currents (both peak and plateau) at different lower light intensities (Figure 22C and D). 
Wt 
3Mt 
A B 
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Figure 21: Spectral and Current properties of ReaChR variants. A) Spectral curve comparison. B)  
Representative current traces mediated by CoChR and its variants in HEK293 cells. Responses were 
generated under voltage clamp (-60 mV) conditions with 1 second (530 nm) light stimulation. Light 
intensities were attenuated by neutral density filters ND 4.5, 4, 3, 2.5, 2 and 1. 
Table 9: Light response properties of ReaChR-Wt and ReaChR-I171M-V302L-N305H (3Mt) variant; 
characterized in HEK293 cells by whole cell patch clamp recordings at 480 nm. Data presented as mean 
± SEM. ND0 = 8.5 x 10
17
 photons/cm
2
s, ND 2.5 = 3.5 x 10
15
 photons/cm
2
s. 
ReaChR 
Variants 
N Off rate (ms) Peak Current (pA) Ratios 
  ND 0 ND 0 ND 2.5 IPla/IP ND2.5/ND0 
Wt 11 414 ± 28 782 ± 69 291 ± 23.34 0.55 0.37 
3Mt 11 935 ± 133.5 841.5 ± 57 385 ± 24.28 0.67 0.46 
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Figure 22: Comparison of current amplitudes at different light intensities of ReaChR variants. A) 
Mean peak currents at ND 0. B) Mean ratio of plateau to peak current at ND 0. C and D) Light intensity 
response curve. Peak and plateau currents were obtained in response to different light intensities of 
530nm. ND0 = 8.5 x 10
17
 photons/cm
2
s, ND 2.5 = 3.5 x 10
15
 photons/cm
2
s. 
As shown in Table 9, the channel off rate for the 3Mts variant observed was 935 
± 134 ms, which is significantly slower than that of the ReaChR-Wt, i.e. 414 ± 28 ms 
(Figure 23A and B). As anticipated, this led to increased current response at lower light 
intensity. In response to low light intensity the ReaChR-3Mts generated 385 ± 24 pA 
current which is significantly larger than that of the ReaChR-Wt (291 ± 23 pA) (Figure 
23C). Upon plotting the off rate against the current, a trend line shows that the current 
amplitude of the ReaChRs is inversely related to its off rate, i.e. slower the off rate 
C 
A B 
D 
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larger is the current amplitude to the low light intensity (Figure 23D), which is consistent 
with proposed hypothesis. 
 
          
           
Figure 23: Kinetic properties of ReaChR variants characterized in HEK293 cells. A) Representative 
traces of 10 ms pulse (ND 0) stimulation, for different variants, to compare off kinetics (deactivation). B) 
Mean off-rates (deactivation time constant) comparison. These deactivation time constants were obtained 
by fitting a single exponential function to the decaying phase of the current evoked by 10 ms pulse at ND 
0, as shown in A. C) Comparison of mean peak currents at ND 2.5 (low light intensity), elicited with 1 
second light pulse of 530 nm. D) The relationship plot between the off-rates and the peak current at low 
light intensity (ND 2.5). Data presented as mean ± SEM error bars. The “n” numbers are indicated in 
white box over the top of the X-horizon at their respective bars. ND0 = 8.5 x 10
17
 photons/cm
2
s, ND 2.5 = 
3.5 x 10
15
 photons/cm
2
s. 
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Figure 24: Light sensitivity comparisons. A) Dosage response curve generated using nonlinear least 
square fitter function; y(x) = {A1-A2/1+(x/x0)
p
} + A2, where A1 = initial y value, A2 = final y value, x0 = center 
value, p = power. B) EPD50, i.e. effective power density to generate half-max current. C) EPD50 vs off 
rate (± SEM) relationship plot. 
Discussion:  
The ReaChR is a chimeric ChR, which was originally optimized for its red 
spectral sensitivity. Its use as an optogenetic tool to restore light responses (via 
optogenetics) in rd1 mice, macaque as well as human retina has recently been reported 
(Sengupta et al., 2016). However, its light sensitivity is low. Here, several point 
mutations were explored to improve ReaChR’s light sensitivity by slowing its kinetics (off 
rate). ReaChR mutations created at the sites corresponding to those improving light 
A B 
C 
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sensitivity of ChR2 failed to enhance its light sensitivity. One possible reason can be the 
difference in their respective molecular determinants of channel function. Importantly, 
since ReaChR is a chimera of three different ChRs (ChR1, vChR1 and vChR2) it is 
difficult to relate the molecular determinants of just any one type of ChR, e.g. ChR2, 
with ReaChR. For instance, ReaChR has its majority of TM domains form VChR1 (see 
Figure 17 on page 47), which is more related to ChR1 (Zhang et al., 2008); and hence, 
ReaChR mutations at the sites corresponding to those enhancing current properties of 
ChR1 may improve its light sensitivity. However, such variants of ChR1 are not 
discovered yet 
Alternatively, mutations screening based on our chimera #24 successfully 
identified variant V302H-N305H, which improved the light sensitivity of ReaChR as a 
consequence of slower off rate. However, its off rate exceeded the projected limit of 1 s. 
Therefore, the mutation I171M combined with V302H-N305H to optimize its off rate. The 
variant ReaChR-3Mts (I171M/V302H/N305H) found to be optimized and more light-
sensitive variant of the ReaChR. 
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CHAPTER 4: SHIFTING SPECTRAL SENSITIVITY OF CoChR 
TOWARDS RED 
Aim 3: To shift CoChR’s spectral sensitivity towards red  
By targeted mutations at the sites predicted to be nearby to β-ionone ring of the 
chromophore ATR. 
Rationale:  
Preliminary data from our laboratory indicated that the Chrimson is less efficient 
than ChR2, ReaChR and CoChR. Thus, red shift in peak spectrum of more efficient 
ChR variant CoChR was desirable. Recently, a polar to nonpolar amino acid difference 
around the β-ionone ring of the chromophore (retinal) has been proposed to be 
responsible for the diverse spectral sensitivity of primate red and green cone 
photoreceptors (Katayama et al., 2015). Interestingly, both Chrimson and ReaChR have 
polar amino acid residues around the β-ionone ring position, e.g. S223 of Chrimson and 
analogous ReaChR-S221 (Figure 5). Moreover, these residues are corresponding to 
one of the four amino acid residues predicted (by Zhang et al., 2008) for VChR1’s red-
shifted spectral sensitivity (see pages 18-19). Additionally, such polarity differences 
among blue light sensitive ChRs (CoChR and ChR2) and green-red light sensitive ChRs 
(ReaChR and Chrimson) revealed at two neighboring residues CoChR-S86-M87 
(Figure 5). Thus, replacing polar and nonpolar residues according to the Chrimson at 
analogous positions in CoChR might shift the spectral sensitivity towards red. To test 
this hypothesis, four of the CoChR’s non-polar residues M87, G161, I163, and M205 
were mutated to polar residues, T, S, S and S, respectively. On the other hand, two 
polar residues S86 and S236 were mutated to a non-polar residue A. Thus, CoChR 
variant S86A/M87T, G161S, I163S, M205S, and S236A were generated.  
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Results:   
For each mutant variant, current response to the short light pulses of 200 ms at 
ND2.5 with different wavelengths ranging from 400 nm to 600 nm was tested. 
Additionally, their off rate and current amplitude (at their respective λmax) were also 
checked. The current amplitudes to each wavelength were normalized to respective 
maximum values (Table 10) then plotted to generate spectral curves. The peak spectral 
sensitivity remained unchanged for all mutant variants tested (Figure 25). However, the 
overall spectral curve for the mutant CoChR-S236A (SA) shifted ~9 nm towards the red 
(Figure 25A and B), and this remained effective with other combination of mutation too, 
i.e. S236A-K264T, SA-LC/TC and SA-3Mts (Figure 25C). On the other hand, the 
spectral curves for the mutations S86A/M87T, G161S, I163S and M205S appeared to 
be narrowed compared to CoChR-Wt. 
The current and kinetic properties of these spectral shift mutants are summarized 
in Table 11. Compared to the CoChR-Wt, the off-rates significantly slowed for the 
spectral-shift mutants S86A-M87T, S236A, S236A-L112C-T139C, SA-K264T and SA-
3Mt (Figure 26 A). Consequently, current at ND 2.5 was also improved for the variants 
S236A, SA/LC/TC and SA-3Mt, compared to the CoChR-Wt (Figure 26 B). However, 
the off-rates of SA/LA/TC and SA-3Mt were too slow (>3 s and 1.5 s respectively, see 
Table 12) to be useful. For any of these variants, no significant difference was found in 
currents at ND 0 (Figure 26C). For the mutant S236A, the ratio of current at ND 2.5 to 
current at ND 0 was not any different from that of the CoChR-Wt (Figure 25D). Hence, 
the improvement in current at low light intensity for CoChR-SA is not a true 
enhancement in its light sensitivity. 
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Figure 25: Spectral curve comparison for CoChR chimera variants. Responses to each wavelength 
(from 400 nm to 560 nm) were recorded under voltage clamp conditions (-60mV) at ND 2.5. A) Spectral 
curves of all variants together, B) Spectral curves of CoChR-Wt and S236A variant, C) Spectral curves of 
S236A/K264T, S36A/LC-TC and S236A/3Mt compared with CoChR-Wt. 
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Table 10: Normalized peak current, at different wavelength of light, of CoChR spectral mutant 
variants. 
 Normalized currents at ND 2.5 
CoChR 
variants 
Wt 
S86A-
M87T 
M205S G161S I163S 
S236A 
(SA) 
SA-
K264T 
SA-
LC/TC 
SA-
3Mts 
λ (nm)          
400 0.29 0.29 0.18 0.22 0.19 0.15 0.15 0.17 0.15 
420 0.51 0.51 0.37 0.40 0.40 0.31 0.31 0.31 0.30 
440 0.72 0.73 0.62 0.64 0.64 0.52 0.52 0.52 0.50 
460 0.92 0.95 0.91 0.92 0.93 0.83 0.83 0.85 0.79 
480 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
500 0.80 0.72 0.70 0.81 0.66 0.90 0.92 0.91 0.92 
520 0.44 0.35 0.30 0.46 0.26 0.59 0.60 0.63 0.61 
540 0.15 0.10 0.08 0.18 0.07 0.24 0.25 0.29 0.18 
560 0.03 0.03 0.03 0.00 0.00 0.07 0.11 0.04 0.06 
Table 11: Light response properties of CoChR spectral mutant variants. 
CoChR 
Variants 
N Off rate (ms) Current  (pA) Ratios 
  ND 0 ND 0 ND 2.5 ND2.5/ND0 
Wt 10 112 ± 11 1465 ± 254 368.52 ± 44 0.29 
S86A/M87T 5 263 ± 33 1415 ± 271 565.96 ± 166.3 0.37 
G161S 5 79 ± 18 787 ± 152 114.89 ± 38 0.13 
I163S 5 110 ± 18 1462 ± 160 234.94 ± 32.6 0.17 
M205S 5 80.4 ± 21.5 1107 ± 335 154.37 ± 75 0.13 
S236A (SA) 5 288 ± 43 1953 ± 405 619.12 ± 126 0.32 
SA/LC-TC 5 3438 ± 664 1228.5 ± 227 872.10 ± 183 0.70 
SA/KT 5 205 ± 27 2321 ± 240 512.20  ± 53.2 0.23 
SA/3Mt 5 1574 ± 115.5 1598 ± 142 818.48  ± 73.6 0.52 
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Figure 26: Light response properties of CoChR spectral mutant variants. 
Discussion: 
From the results obtained, it can be concluded that the residues targeted are not 
capable of shifting peak spectral sensitivity of the CoChR, at least not independently. 
However, the mutation at S236 shifted the overall spectral curve towards red, which 
suggests that it has some role in shifting the spectrum but not the peak sensitivity. 
Further analysis is required for identification of amino acid residues that influence 
spectral sensitivity of the CoChR. One possible approach attempted is discussed in next 
section.  
A B 
C C 
65 
 
 
 
By chimera approach to identify important regions for spectral sensitivity of the 
CoChR and Chrimson. 
Rationale: 
Alternatively, earlier studies have demonstrated that determinants of wavelength 
sensitivity reside on TM5 (E) and/or TM6 (F) for ChR2 and ChR1 (Wang et al., 2009; 
Wen et al, 2010). Moreover, preliminary data also suggest involvement of TM4, TM5 
and TM7 in spectral red-shift (unpublished data.). Additionally, polar residues of red 
sensitive ChR variants described above are also located on ECL1, TM2, TM5, TM6 and 
TM7 (Figure 5). Thus, if not these proposed polar residue mutants alone, some other 
residues of TM4, TM5, TM6 and/or TM7 in combination could be the determinant of 
spectral sensitivity. To test this several chimeras of CoChR and Chrimson were 
generated. A schematic of chimeras designed by replacing different domains of the 
CoChR with that of Chrimson, in different combinations, are shown in Figures 27 and 28. 
All of the chimera gene sequences were synthesized and obtained from the GeneScript 
(Piscataway, NJ, USA). 
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Figure 27: Schematic of proposed chimeras (Part-1). On the top left, first two represents CoChR (cyan) 
and Chrimson (pink) domains schematic as a reference for the different chimeras. 
 
67 
 
 
 
 
Figure 28: Schematic of proposed chimeras (Part-2). 
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Figure 29: Spectral curve comparison for CoChrim chimera variants. Responses to each wavelength 
(from 400 nm to 560 nm) were recorded under voltage clamp conditions (-60mV) at ND 2.5. 
Results: 
Most of the chimeras did not express well and/or were toxic to the cells. Hence, 
out of the total 15 chimeras, only the chimeras CoChrim-1-LC, CoChrim-2-LC, 
CoChrim-4-LC and CoChrim-C’ could be tested for their spectral sensitivity. The peak 
spectral sensitivity of the chimera CoChrim-4-LC found to shift from 480 nm to 460 nm 
(Figure 29). For all other tested chimeras, peak spectral sensitivity remained unchanged. 
None of the chimeras showed red shift in their spectral curve compared to the CoChR-
Wt. Moreover, all four chimeric variants generated very small currents compared to the 
CoChR-Wt (Table 13). 
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Table 12: Normalized peak current, at different wavelength of light, of CoChR and Chrimson 
chimeras. 
 Normalized currents at ND 2.5 
CoChR 
Chimeras 
CoChR-Wt 
CoChrim-1-
LC 
CoChrim-2-
LC 
CoChrim-4-
LC 
CoChrim-C' 
λ (nm)      
380 0.12 0.00 0.10 0.00 0.08 
400 0.32 0.19 0.25 0.17 0.24 
420 0.55 0.40 0.42 0.38 0.37 
440 0.76 0.65 0.66 0.64 0.61 
460 0.95 0.95 0.96 1.00 0.92 
480 1.00 1.00 1.00 0.90 1.00 
500 0.83 0.71 0.82 0.70 0.72 
510 0.66 0.51 0.65 0.51 0.52 
520 0.47 0.37 0.47 0.37 0.32 
530 0.29 0.22 0.38 0.18 0.19 
550 0.07 0.00 0.17 0.00 0.07 
Table 13: Peak current responses of the chimeras at different wavelength of light. 
 Mean currents ± SEM (pA) at ND 2.5 
CoChR 
Chimeras 
CoChR-Wt 
CoChrim-1-
LC 
CoChrim-2-
LC 
CoChrim-4-
LC 
CoChrim-C' 
λ(nm) n = 3 n = 2 n = 2 n = 2 n = 2 
380 63.7 ± 21 0.0 ± 0.0 8.6 ± 0.5 0.0 ± 0.0 13 ± 3 
400 173 ± 46 7.5 ± 7.5 22 ± 4 7 ± 7 38.4 ± 0.0 
420 295 ± 60 16 ± 2.7 36.2 ± 3.4 16.1 ± 5.1 60 ± 10 
440 408 ± 63 26 ± 6.2 58 ± 5.8 27 ± 11.4 99.3 ± 15.5 
460 509 ± 60 38.3 ± 8.4 84 ± 6.2 42 ± 15.5 148 ± 21 
480 534 ± 60.3 40 ± 8.5 87.2 ± 6.9 38 ± 14.4 162 ± 23 
500 443 ± 77.2 28.5 ± 5.6 72 ± 10.4 29.3 ± 11 116 ± 13.3 
510 350± 79 20.3 ± 4 56.3 ± 10.6 21.5 ± 8 83.4 ± 12.2 
520 251 ± 69.5 15 ± 2 41 ± 8 15.4 ± 5.5 51.5 ± 5.6 
530 157 ± 53 9 ± 1 33 ± 7 7.5 ± 7.5 30.2 ± 5 
550 39.3 ± 14 0.0 ± 0.0 15 ± 3.7 0.0 ± 0.0 11 ± 3 
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Discussion:  
Poor or toxic expression in HEK cells significantly limited the spectral sensitivity 
evaluation of majority of the designed chimeras. However, from the tested chimera 
results, it appears that the residues of the TM1, TM2, TM4 and the C’ terminal do not 
play a major role in red-spectral selectivity, at least not by themselves alone. In addition, 
some residues of the TM3, TM5, TM6 and TM7 seem to be very important for the ChR 
expression. Careful screenings of amino acid differences on these TMs, by replacing 
one residue at a time, to exclude residues affecting the expression so severely might be 
a way to test their (TM3, 5, 6 and 7) effect on spectral sensitivity. Alternatively, one can 
also screen for the residues affecting spectral sensitivity. Nevertheless, it is important to 
keep in mind that spectral properties can be the cumulative effect of different residues 
on all or some TMs, and hence, more thorough investigation is required to develop/shift 
the spectral sensitivity towards red. 
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APPENDIX 
Table 14: The amino acid codes and categories. 
Amino acid codes and types 
Amino acid 
Three letters 
code 
Single letter 
code 
Amino acid type 
Arginine Arg R Positively charged 
Histidine His H Positively charged, Sulfur containing 
Lysine Lys K Positively charged 
Aspartic aicd Asp D Negatively charged 
Glutamic acid Glu E Negatively charged 
Serine Ser S Polar 
Threonine Thr T Polar 
Aspargine Asn N Polar 
Glutamine Gln Q Polar 
Cysteine Cys C Special class, Sulfur containing 
Glycine Gly G Special class 
Proline Pro P Special class 
Alanine Ala A Hydrophobic 
Iso-leucine Ile I Hydrophobic 
Leucine Leu L Hydrophobic 
Metheonine Met M Hydrophobic 
Phenylalanine Phe F Hydrophobic 
Tryptophan Trp W Hydrophobic 
Tyrosine Tyr Y Hydrophobic 
Valine Val V Hydrophobic 
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Discovery of channelrhodopsin (ChR), a light sensitive protein from green algae, 
has revolutionized the field of neuroscience research by empowering scientist to control 
neuron through the light, the technology popularly known as optogenetics. The ChR 
based optogenetics is one of the promising approaches for treating blindness caused by 
photoreceptor degenerative diseases such as retinitis pigmentosa (RP) and age-related 
macular degeneration (AMD). Fundamentally, the approach is about imparting light 
sensitivity to surviving inner retinal cells by ectopic expression of genetically encoded 
light sensitive proteins, such as ChR2. Although the concept of optogenetic approach 
has been proved by using ChR2, a major obstacle of using the wild type ChR2 or in 
general ChRs for vision restoration is their low light-sensitivity. With the molecular 
engineering approach more light sensitive variants of ChR2 have been created recently, 
however, their light sensitivity remained 2-3 log units below the threshold of cone 
photoreceptors. Additionally, most of the ChR variants with improved light sensitivity are 
blue light sensitive. Since the longer wavelength light can have better tissue penetration 
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and less photo-toxicity, the development of ChR with higher light-sensitivity and red-
shifted peak spectra (λmax) was desired. In this study, two newly reported ChRs, the 
CoChR (Chloromoas oogama ChR) and the ReaChR (Red activable ChR, a chimera 
variant) were chosen to improve their light sensitivity by molecular engineering. The 
CoChR was chosen because of its larger photocurrent compared to that of ChR2, while 
ReaChR was selected because of its red-shifted peak spectral sensitivity (λmax). 
Additionally, attempts were made to shift the λmax of the CoChR towards the red. For 
CoChR, three different sites with specific mutations, specifically H94E (HE), L112C (LC) 
and K264T (KT) were identified, which together created the most light-sensitive CoChR-
3Mt (CoChR-HE/LC/KT). The CoChR-3Mt markedly enhances photocurrent to low light 
intensity and, thus, increases operational light sensitivity in compared to the wild type 
CoChR (CoChR-Wt). The enhanced light sensitivity was found to be correlated with the 
slower off-kinetics. However, the λmax of CoChR could not shift towards longer 
wavelengths (red) either by site-direct mutagenesis or by chimera approaches. This 
suggested that the spectral sensitivity of the ChR, in general, is tightly regulated by a 
complex mechanism that is yet to be revealed. For ReaChR, a combination of three 
mutations, specifically I171M-V302L-N305H (IM-VL-NH), was identified which 
moderately enhanced its light sensitivity. Again, the enhanced light sensitivity was 
correlated with slower off-kinetics. 
In conclusion, the CoChR-3Mt was found to be the most light-sensitive ChR 
variant that can be a better optogenetic tool for vision restoration. 
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